A clinical trial to evaluate the preventive effects of the investigational medicinal product denosumab (brand name: Stoboclo prefilled syringe) on bone metabolism in obese participants who have achieved =5% weight loss after treatment with GLP-1 receptor agonists (GLP-1 RAs) and who possess risk factors for bone metabolic disorders.

Authors
Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2025
This article has no abstract
Epistemonikos ID: 6ad0678f05528e054e0466a7de80fd600d3c3fda
First added on: Apr 24, 2026